These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 495015)

  • 1. [Inhibitory actions of acidic polymucosaccharides and sulphuric polysaccharides on platelet aggregation (author's transl)].
    Asada T; Igarashi N; Mukoyama H; Shiba T
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):548-9. PubMed ID: 495015
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of histone-chondroitin sulphate A complexes on blood platelet aggregation.
    Kłoczko J; Czaczkowska T; Wojtukiewicz M; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):545-9. PubMed ID: 2431977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of histones F1 and F2 alpha 1, chondroitin sulfate A and their complexes on platelet aggregation induced by ADP and arachidonic acid].
    Czaczkowska T; Kłoczko J; Bielawiec M
    Acta Haematol Pol; 1986; 17(1-2):22-6. PubMed ID: 3096061
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
    Artery; 1980; 8(5):410-5. PubMed ID: 6783013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
    Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of atherogenesis in hypercholesterolemic rabbits by chondroitin-6-sulfate.
    Matsushima T; Nakashima Y; Sugano M; Tasaki H; Kuroiwa A; Koide O
    Artery; 1987; 14(6):316-37. PubMed ID: 3118854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of 35 cases of arthrosis treated with chondrotiine sulphuric acid (author's transl)].
    Thilo G
    Schweiz Rundsch Med Prax; 1977 Dec; 66(52):1696-9. PubMed ID: 341111
    [No Abstract]   [Full Text] [Related]  

  • 8. [The influence of heparin on the platelet aggregation and serum lipids (author's transl)].
    Tsuchima M; Walter E; Weber E; Schlierf G
    Rinsho Ketsueki; 1981 Jul; 22(7):1053-60. PubMed ID: 7328765
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of chondroitin sulphate and heparin on the growth and agglomeration of calcium oxalate monohydrate crystals in vitro.
    Gjaldbaek JC
    Clin Chim Acta; 1982 Apr; 120(3):363-5. PubMed ID: 6804134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of polymer size and epsilon-amino groups in polylysine-platelet interaction.
    Mohammad SF; Chuang HY; Mason RG
    Thromb Res; 1977 Feb; 10(2):193-202. PubMed ID: 850906
    [No Abstract]   [Full Text] [Related]  

  • 11. Human platelet interactions with surfaces of type I collagen, chondroitin-4-sulphate, and chondroitin-6-sulphate in vitro.
    Umemura Y; Huskey RA; Anderson JM
    Biomaterials; 1988 Mar; 9(2):133-7. PubMed ID: 3130901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of drugs used in the treatment of thrombotic and hemorrhagic conditions on the erythrocyte aggregation].
    Lakin KM; Ovnatanova MS
    Kardiologiia; 1977 May; 17(5):79-83. PubMed ID: 886757
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Törngren S; Norén I; Forsskåhl B; Sipilä H
    Thromb Res; 1983 Jun; 30(5):527-34. PubMed ID: 6412390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin and lipid metabolism (author's transl)].
    Naito C; Kume S; Watanabe T
    Rinsho Ketsueki; 1981 Jul; 22(7):1023-9. PubMed ID: 7328762
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo release of anti-Xa clotting activity by a heparin analogue.
    Thomas DP; Barrowcliffe TW; Merton RE; Stocks J; Dawes J; Pepper DS
    Thromb Res; 1980 Mar; 17(6):831-40. PubMed ID: 6773178
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
    Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
    Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of heparin on platelet functions (author's transl)].
    Ikeda Y; Handa M; Yoshii Y; Ando Y; Yamamoto M; Watanabe K
    Rinsho Ketsueki; 1981 Jul; 22(7):1001-9. PubMed ID: 7328759
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structural variations in acidic mucopolysaccharides (author's transl)].
    Seno N
    Ryumachi; 1977 May; 17(3):359-68. PubMed ID: 144325
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular action of drugs affecting platelet functions (author's transl)].
    Verstraete M
    Rev Med Brux; 1981 Mar; 2(3):301-8. PubMed ID: 6262895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.